| Lam, Cindy L |
NCT05248412: The Long-term Spill-over Impact of COVID-19 on Health and Healthcare of People With Non-communicable Diseases |
|
|
| Recruiting | N/A | 250000 | RoW | COVID-19 outbreaks | The University of Hong Kong | Diabetes Mellitus, Hypertension, Cancer, Cardiovascular Diseases, Chronic Respiratory Disease, Kidney Disease, Chronic, Noncommunicable Diseases | 06/22 | 06/26 | | |
NCT04299685: Family Factors of Eating Habits Among Adolescents |
|
|
| Completed | N/A | 25 | RoW | Interview | The University of Hong Kong | Eating Habit, Healthy Diet | 07/22 | 10/22 | | |
NCT04881383: Development and Validation of DM and Pre-DM Risk Prediction Model |
|
|
| Completed | N/A | 1014 | RoW | OGTT and HbA1c | The University of Hong Kong | Diabetes Mellitus, Pre Diabetes | 06/23 | 09/23 | | |
TRACC, NCT04302974: Cohort Study on Patient Outcomes, Effectiveness and Cost-effectiveness of Intervention Programmes for DM/HT Patients |
|
|
| Completed | N/A | 100000 | RoW | Different structures and processes of primary care management strategies, Multi-disciplinary Risk Factor Assessment and Management Programmes for diabetes (RAMP-DM), Multi-disciplinary Risk Factor Assessment and Management Programmes for hypertension (RAMP-HT), Patient Support Call Centre (PSCC) | The University of Hong Kong | Hypertension, Diabetes Mellitus, Cardiovascular Diseases, Morbidity, Multiple, Kidney Disease, Chronic, Death | 06/24 | 09/24 | | |
NCT03918720: The Health and Effect of Health Empowerment Programmes Among Families in Tung Chung |
|
|
| Completed | N/A | 1200 | RoW | Trekkers Family Health Empowerment Programme, Trekkers Family | The University of Hong Kong | Quality of Life, Empowerment | 12/22 | 06/23 | | |
| Wong, William |
RAINBOW, NCT04061512: Rituximab and Ibrutinib (RI) Versus Dexamethasone, Rituximab and Cyclophosphamide (DRC) as Initial Therapy for Waldenström's Macroglobulinaemia |
|
|
| Recruiting | 2/3 | 148 | Europe | Dexamethasone, cyclophosphamide, rituximab, Rituximab, ibrutinib | University College, London, Janssen-Cilag Ltd. | Waldenstrom Macroglobulinemia | 03/30 | 03/30 | | |
| Yu, Esther YT |
NCT04129515: NovoTTF-200A + Pembrolizumab In Melanoma Brain Metastasis |
|
|
| Not yet recruiting | 1/2 | 30 | US | NovoTTF-200A, Pembrolizumab, Keytruda® | Brown University, NovoCure Ltd. | Metastatic Melanoma, Melanoma Brain Metastasis | 01/25 | 01/27 | | |
NCT04875780: A Smartphone-based Intervention for Diabetes Prevention in Overweight Chinese Adults With Pre-diabetes |
|
|
| Recruiting | N/A | 282 | RoW | Digital diabetes prevention app intervention, Web-based diabetes prevention curriculum, Goal setting and self-monitoring, Virtual social support group, Digital weight loss tracking app intervention, Wait-list control (usual care) | The University of Hong Kong | Pre-diabetes | 05/24 | 05/24 | | |
| Ribas, Andressa |
| Recruiting | 3 | 738 | Europe, US, RoW | Docetaxel 75 mg/m2, Docetaxel 60 mg/m2, Radium-223 | Memorial Sloan Kettering Cancer Center, Bayer | Prostate Cancer | 06/26 | 06/26 | | |
FOENIX-CCA4, NCT05727176: Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement |
|
|
| Recruiting | 2 | 120 | Europe, Japan, US, RoW | TAS-120, Futibatinib | Taiho Oncology, Inc. | Advanced Cholangiocarcinoma, FGFR2 Fusions, Gene Rearrangement | 06/25 | 06/26 | | |
